CGQGX
Price
$26.25
Change
+$0.49 (+1.90%)
Updated
Sep 19 closing price
CGRGX
Price
$26.38
Change
+$0.49 (+1.89%)
Updated
Sep 19 closing price
Ad is loading...

CGQGX vs CGRGX

Header iconCGQGX vs CGRGX Comparison
Open Charts CGQGX vs CGRGXBanner chart's image
American Funds Growth Portfolio ABLE-A
Price$26.25
Change+$0.49 (+1.90%)
VolumeN/A
CapitalizationN/A
American Funds Growth Portfolio ABLE-F-2
Price$26.38
Change+$0.49 (+1.89%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CGQGX vs CGRGX Comparison Chart
Loading...
VS
CGQGX vs. CGRGX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGQGX is a Hold and CGRGX is a Hold.

FUNDAMENTALS
Fundamentals
CGQGX (19.5B) and CGRGX (19.5B) have equal amount of cash in the bank . CGRGX pays higher dividends than CGQGX: CGRGX (0.84) vs CGQGX (0.70). CGQGX was incepted earlier than CGRGX: CGQGX (6 years) vs CGRGX (4 years). CGQGX (1.00) and CGRGX (1.00) have comparable annual turnover. CGQGX (250) and CGRGX (250) have matching initial minimum investment requirements. CGRGX (26.78) and CGQGX (26.56) have marching annual gain over last year.
CGQGXCGRGXCGQGX / CGRGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years4 years-
Gain YTD15.82715.94399%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B19.5B100%
Annual Yield % from dividends0.700.8483%
Returns for 1 year26.5626.7899%
Returns for 3 years-2.66-2.10127%
Returns for 5 years43.37N/A-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMUCX12.690.01
+0.11%
Columbia Select Mid Cap Value C
GARGX10.61N/A
N/A
Goldman Sachs Global Rl Estt Secs A
KLGDX49.92N/A
N/A
NYLI WMC Growth Class R6
VHCIX142.53-0.14
-0.10%
Vanguard Health Care Index Admiral
BRUMX16.97-0.03
-0.18%
MFS Blended Research Value Equity R4